|
Volumn 3, Issue 11, 2017, Pages 1595-
|
Chimeric antigen receptor (CAR) T-Cell therapy
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHIMERIC ANTIGEN RECEPTOR;
APLASIA;
B CELL APLASIA;
B LYMPHOCYTE;
BLOOD CELL COUNT;
BLOOD TRANSFUSION;
CANCER IMMUNOTHERAPY;
CHIMERIC ANTIGEN RECEPTOR T CELL;
CYTOKINE RELEASE SYNDROME;
FATIGUE;
HUMAN;
INFECTION;
LEUKAPHERESIS;
LEUKEMIA;
NEUROLOGICAL COMPLICATION;
NOTE;
PERSONALIZED MEDICINE;
T LYMPHOCYTE;
ADOPTIVE IMMUNOTHERAPY;
IMMUNOLOGY;
NEOPLASM;
PROCEDURES;
TRANSPLANTATION;
TREATMENT OUTCOME;
HUMANS;
IMMUNOTHERAPY, ADOPTIVE;
NEOPLASMS;
RECEPTORS, CHIMERIC ANTIGEN;
T-LYMPHOCYTES;
TREATMENT OUTCOME;
|
EID: 85036583699
PISSN: 23742437
EISSN: 23742445
Source Type: Journal
DOI: 10.1001/jamaoncol.2017.2989 Document Type: Note |
Times cited : (20)
|
References (0)
|